【橙心研选】每日研究精粹:科伦博泰首次覆盖报告、洛阳钼业首次覆盖报告、公司季报&年报点评

平安研究
25 Apr

重要声明本公众号仅面向平安证券客户中的专业投资者,根据《证券期货投资者适当性管理办法》,若您非平安证券客户中专业投资者,为保证服务质量、控制投资风险,请勿订阅或以任何形式转载本公众号中的信息。请务必阅读文末"重要声明"以及"评级说明与声明"。今日概览01. 公司观点医药 |科伦博泰生物-B(6990.HK)首次覆盖报告:朝向研发销售一体化转型,芦康沙妥珠单抗国内已获批两项适应症新材料 |洛阳钼业...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10